english.prescrire.org > Prescrire International > N°283 - July 2026

n°283

July 2026

Issue Contents
Editorial

Free  A trustworthy companion

p.171

Marketing Authorisations


Elafibranor (Iqirvo°) in primary biliary cholangitis

p.173-175

Editors' opinion. Haste

p.174

Palopegteriparatide (Yorvipath°) in chronic hypoparathyroidism

p.176-177

Oral semaglutide (Rybelsus°) in type 2 diabetes

p.177-178

Blinatumomab (Blincyto°) in acute lymphoblastic leukaemia in adults, added to consolidation chemotherapy

p.178-179

Blinatumomab (Blincyto°) in acute lymphoblastic leukaemia from 1 month of age

p.180

Editors' opinion. Plausibility

p.180

Risankizumab (Skyrizi°) in ulcerative colitis

p.181

Empagliflozin + metformin (Synjardy°) in type 2 diabetes from 10 years of age

p.181

Midazolam oromucosal solution (Buccolam°) for convulsive seizures in adults

p.182

Editors' opinion. Aspects

p.182

Market withdrawal of the liraglutide originator Victoza°: illustration of an anti-generic strategy

p.183

Adverse Effects


In-utero exposure to mesalazine: renal disorders, haematological disorders and possibly malformations

p.184-185

GLP-1 agonists: thyroid cancer (continued)

p.185

Reduced exposure to nomegestrol and chlormadinone: fewer meningiomas

p.186

Common stem: -dil, dil-

p.186

Pregabalin, gabapentin: abuse (continued)

p.187

Trimethoprim and sulfamethoxazole: aseptic meningitis

p.187

EGFR tyrosine kinase inhibitors such as osimertinib: reactivation of hepatitis B

p.188

Common stem: -onidine

p.188

Outlook


Suzetrigine: media hype over a little-tested new drug

p.189-191

Extending drug shelf life: potential economic and environmental benefits

p.191-193

Cyproterone-related meningioma: drug companies, a doctor and a pharmacist held liable

p.194

Free  Biosimilar drugs: consultation on streamlining their development and evaluation

p.195

Masthead


Free  Masthead

p.170

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe